Tsai, Pei-HsuanPei-HsuanTsaiChen, Yu-TingYu-TingChenJAU-YU LIAUHuang, Miao-HuiMiao-HuiHuangHONG-MING HSUYeong, Eng-KeanEng-KeanYeongCHIEN-CHING HUNG2022-01-082022-01-082021-121684-1182https://scholars.lib.ntu.edu.tw/handle/123456789/591912Leishmaniasis is prevalent in Southern Europe, the Middle East, India, Africa, and Central and South America. Cutaneous leishmaniasis may spontaneously heal over time without treatment; however, risk of visceral dissemination and the impact of cosmetic defect are important concerns. We report a Case of cutaneous leishmaniasis in a patient who ever traveled to Mexico before the onset of a deteriorating wound around the swollen left eyebrow. A diagnosis of infection with Leishmania mexicana was made based on histopathological examination and molecular identification. Systemic treatment with liposomal amphotericin B and ketoconazole were administered with gradual healing of the lesion. Also, this traveler case implicates that the spread of endemic parasitic diseases may be a concealed risk on the public health for Taiwan underlying globalization.enCutaneous leishmaniasis; Ketoconazole; Leishmania mexicana; Liposomal amphotericin B; Taiwan[SDGs]SDG3[SDGs]SDG17amphotericin B; amphotericin B lipid complex; ketoconazole; protozoal DNA; adult; case report; cutaneous leishmaniasis; genetics; human; isolation and purification; Leishmania mexicana; male; pathology; travel related disease; treatment outcome; Adult; Amphotericin B; DNA, Protozoan; Humans; Ketoconazole; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Travel-Related Illness; Treatment Outcome10.1016/j.jmii.2020.07.007327416802-s2.0-85088994649WOS:000731577700019https://scholars.lib.ntu.edu.tw/handle/123456789/551006